These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 28165246)
1. Ultrasound Molecular Imaging of Angiogenesis Using Vascular Endothelial Growth Factor-Conjugated Microbubbles. Wang J; Qin B; Chen X; Wagner WR; Villanueva FS Mol Pharm; 2017 Mar; 14(3):781-790. PubMed ID: 28165246 [TBL] [Abstract][Full Text] [Related]
2. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis. Anderson CR; Rychak JJ; Backer M; Backer J; Ley K; Klibanov AL Invest Radiol; 2010 Oct; 45(10):579-85. PubMed ID: 20733505 [TBL] [Abstract][Full Text] [Related]
3. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Weller GE; Wong MK; Modzelewski RA; Lu E; Klibanov AL; Wagner WR; Villanueva FS Cancer Res; 2005 Jan; 65(2):533-9. PubMed ID: 15695396 [TBL] [Abstract][Full Text] [Related]
4. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118 [TBL] [Abstract][Full Text] [Related]
5. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339 [TBL] [Abstract][Full Text] [Related]
6. Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See? Wang S; Herbst EB; Mauldin FW; Diakova GB; Klibanov AL; Hossack JA Invest Radiol; 2016 Dec; 51(12):758-766. PubMed ID: 27654582 [TBL] [Abstract][Full Text] [Related]
7. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825 [TBL] [Abstract][Full Text] [Related]
8. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Korpanty G; Carbon JG; Grayburn PA; Fleming JB; Brekken RA Clin Cancer Res; 2007 Jan; 13(1):323-30. PubMed ID: 17200371 [TBL] [Abstract][Full Text] [Related]
9. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma. Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557 [TBL] [Abstract][Full Text] [Related]
10. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer. Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176 [TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Pysz MA; Foygel K; Rosenberg J; Gambhir SS; Schneider M; Willmann JK Radiology; 2010 Aug; 256(2):519-27. PubMed ID: 20515975 [TBL] [Abstract][Full Text] [Related]
12. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts. Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775 [TBL] [Abstract][Full Text] [Related]
13. Dual-Targeted Microbubbles Specific to Integrin αVβ3 and Vascular Endothelial Growth Factor Receptor 2 for Ultrasonography Evaluation of Tumor Angiogenesis. Yuan HX; Wang WP; Wen JX; Lin LW; Exner AA; Guan PS; Chen XJ Ultrasound Med Biol; 2018 Jul; 44(7):1460-1467. PubMed ID: 29706409 [TBL] [Abstract][Full Text] [Related]
14. Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects. Baetke SC; Rix A; Tranquart F; Schneider R; Lammers T; Kiessling F; Lederle W Radiology; 2016 Feb; 278(2):430-40. PubMed ID: 26313618 [TBL] [Abstract][Full Text] [Related]
15. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Rychak JJ; Graba J; Cheung AM; Mystry BS; Lindner JR; Kerbel RS; Foster FS Mol Imaging; 2007; 6(5):289-96. PubMed ID: 18092513 [TBL] [Abstract][Full Text] [Related]
16. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
17. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent. Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217 [TBL] [Abstract][Full Text] [Related]
20. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent. Abou-Elkacem L; Wilson KE; Johnson SM; Chowdhury SM; Bachawal S; Hackel BJ; Tian L; Willmann JK Theranostics; 2016; 6(11):1740-52. PubMed ID: 27570547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]